Emberion develops and produces graphene photonics and electronics that will revolutionise infrared photodetectors and thermal sensors in applications ranging from hyperspectral and thermal imaging to night vision and X-ray detection.
The mission of EMBL-EBI is to: provide freely available data and bioinformatics services to all facets of the scientific community in ways that promote scientific progress; contribute to the advancement of biology through basic investigator-driven research in bioinformatics; provide advanced bioinformatics training to scientists at all levels; and help disseminate cutting-edge technologies to industry. . The research and service activities of EMBL-EBI span the entire spectrum of life science and remain at the cutting edge of the computational sciences. All our major data resources are the products of international collaborations. We work with other data providers to ensure that our data repositories, and those of our collaborators, are comprehensive and up to date. We also actively participate in international efforts to develop data standards.. . The EMBL-EBI Industry Programme engages our industrial users with the latest bioinformatics research, service development, standards activities, pre-competitive opportunities and training https://www.ebi.ac.uk/industry.
Empyrean Therapeutics is focused on developing next generation off-the-shelf cell therapies to enable global and affordable cures for cancer and rare disease. We are building unique technologies, cellular assets and engineering processes which combine to deliver a powerful platform for rapidly manufacturing cellular drugs with novel disease fighting properties. . . Headquartered at the Babraham Research Campus, south of Cambridge, and working with leading clinical partners and academic experts, we are combining world class skills in gene editing with expertise in stem cell programming and precise genetic control to unlock the true potential of designer cellular medicines.
Strategic and finance advisory
Immunotherapeutics company targeting a new class of tumour specific antigens
Essen BioScience is a world leader in the field of innovative cell-based assays, reagents, instrumentation and custom services for discovery research. Our specialities include phenotypic 'live content' kinetic imaging assays based around IncuCyte Zoom (e.g. angiogenesis, neurite outgrowth, cell migration/invasion, apoptosis etc.) and high throughput automated electrophysiology for ion channel drug discovery and safety (e.g. hERG assays). Our live content imaging solution has been adopted by laboratories across all 10 of the world’s top pharmaceutical companies as well as more than 150 leading biotechnology and academic research institutions.
Selcia Ltd headquartered in Ongar, Essex, UK, is a leading worldwide provider of contract research services. Selcia Discovery provides integrated small molecule drug discovery, including general medicinal chemistry and biology capabilities, applicable across all target classes with a particular strength in three unique and highly synergistic technologies: (1) medicinal chemistry on complex natural products; (2) capillary electrophoresis-based fragment and natural product screening; and (3) peptidyl-prolyl isomerase targets (cyclophilins, FKBPs, Pin1, together called PPIases). Selcia Radiolabelling specialises in GMP radiolabelled API and in 14C custom radiolabelling for metabolism, distribution and environmental fate studies.
No data available
No data available
Field Fisher Waterhouse is a UK Top 30 law firm with over 130 partners and over 260 other lawyers offering the full range of legal services. . . Life sciences clients choose to work with us because we have a substantial team of exceptional lawyers, each with their particular specialism, but who at the same time know the major commercial, legal and regulatory issues affecting this industry sector. . . They also appreciate that when we say full service, we really can deliver on all counts, be it advising on regulatory matters, corporate and commercial issues, IP licensing and litigation, competition law issues, compliance with data privacy requirements, complex tax arrangements, trade marks, employment and real estate. . . Through our network of offices in London, Manchester, Brussels, Hamburg and Paris our clients understand that they will get real value from our flexible approach to teamwork and our willingness to shape our structures and way of working to meet their specific needs. . . This commercial attitude, combined with our empowering and down-to earth style, means you can trust us to provide you with the best possible legal solutions. . . One of our key strengths is our focus on industry sectors such as life sciences, with expertise in the pharmaceutical, biotechnology and medical devices industries. . . By pooling our expertise in the life sciences sector across different legal disciplines and our European offices into an industry group, we can provide you with a joined-up approach to your legal issues. It enables us to keep up-to-date with developments in the sector, delivering realistic and practical solutions to our clients' issues. . . Many of our lawyers have a scientific or medical background. This enables us quickly to understand the technology that underpins, and gives value to, our life sciences clients' businesses. . . Our Life Sciences group works with clients at all stages of innovation, from bench to bedside and helps companies to develop and grow their businesses within the strict regulatory requirements that can apply in this sector. During the various stages of growth our lawyers help pharmaceuticals clients with: . regulatory compliance, approval and issues arising with competent authorities . licensing, collaboration and marketing agreements . patent litigation . data protection and privacy . trade mark registration and litigation . clinical trial agreements and regulation . supply, distribution, manufacturing and tooling agreements . corporate finance and M&A . competition & EU regulatory (including REACH) . outsourcing projects and services . real estate, employment and pensions . tax planning and valuation